How licensing agreements can save lives in low- and middle income countries

Recent Developments in licensing In July 2022, ViiV Healthcare, the manufacturer of cabotegravir, signed a voluntary licensing agreement with the Medicines Patent Pool (MPP). This agreement allows generic manufacturers to produce and supply cabotegravir in 90 low- and middle-income countries. Continue reading How licensing agreements can save lives in low- and middle income countries